RF360 high-resolution system for ADME assays

Monday, 07 June, 2010 | Supplied by: Agilent Technologies Australia Pty Ltd


Biocius Life Sciences and Agilent Technologies have released the RF360 high-resolution system for high-throughput screening of in-vitro ADME assays.

Combining the accurate mass capabilities of Agilent’s time-of-flight mass spectrometers and the sample processing speed of RapidFire technology, the instrument eliminates the method development bottleneck in drug discovery.

RapidFire technology combined with TOF mass spectrometers enables a range of ADME assays, including drug-drug interaction, metabolic stability, Caco, PAMPA and others.

When performing such assays with the system, a prior knowledge of the test compound is not required, as data is acquired in full scan TOF-MS mode.

Post acquisition, the relevant data is extracted using RapidFire software, eliminating the time-consuming and labour-intensive steps of LC/MS method development and batch analysis.

Online: www.agilent.com
Phone: 03 9566 1117
Related Products

Lumiprobe SynaptoProbe Red dye for visualising synaptic vesicles in living neurons

Lumiprobe's SynaptoProbe Red is an analogue of FM 4-64, a widely used red fluorescent dye for...

Parse Biosciences Evercode Low Input Fixation kits for cells and nuclei

The kits empower researchers who have a small number of starting cells or nuclei who ordinarily...

EpigenTek MethylFlash Hydroxymethylated DNA Quantification Kit (Fluorometric)

The kit is a complete set of optimised buffers and reagents to fluorometrically quantify global...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd